Valuation: MEDADVISO

Market Cap 89.32L 62.67L 55.94L 51.61L 46.89L 87.96L 59Cr 6.22Cr 2.45Cr 31Cr 2.35Cr 2.3Cr 99Cr P/E 2025
-0.76x
P/E 2026 -1.76x
Enterprise Value -5L -3L -3L -3L -2L -5L -3.1Cr -32.44L -12.78L -1.62Cr -12.28L -12.01L -5.14Cr EV / Sales 2025
0.92x
EV / Sales 2026 -0.05x
Free-Float
68.95%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Executive Officer 46 07/11/2025
Chief Tech/Sci/R&D Officer - 30/06/2020
Corporate Secretary - 13/04/2026
Director TitleAgeSince
Director/Board Member - 10/08/2021
Chairman 67 01/04/2025
Director/Board Member 46 07/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 62.67L
-2.52%-2.86%+19.28%+45.69% 25TCr
-1.76%-0.76%+5.34%+11.62% 16TCr
+3.67%+3.74%-15.78%+66.29% 15TCr
+3.37%+4.24%-55.70%-8.07% 6.67TCr
-0.06%+0.77%-15.38%-11.07% 5.21TCr
+0.62%+3.04%+11.25%+60.96% 5.22TCr
+1.91%+2.26%+17.24%+29.66% 5.19TCr
-2.17%-0.95%+19.21%+59.20% 4.9TCr
-0.41%+2.58%+30.67%+79.62% 4.48TCr
Average +0.01%+1.50%+1.79%+37.10% 9.8TCr
Weighted average by Cap. -1.21%+0.55%+2.88%+38.06%

Financials

2025 2026
Net sales 6.3Cr 4.42Cr 3.95Cr 3.64Cr 3.31Cr 6.2Cr 418.72Cr 44Cr 17Cr 219.37Cr 17Cr 16Cr 694.96Cr 3.4Cr 2.38Cr 2.13Cr 1.96Cr 1.78Cr 3.34Cr 225.72Cr 24Cr 9.31Cr 118.26Cr 8.94Cr 8.75Cr 374.63Cr
Net income -6.02Cr -4.22Cr -3.77Cr -3.48Cr -3.16Cr -5.93Cr -400.2Cr -42Cr -17Cr -209.67Cr -16Cr -16Cr -664.22Cr -43.09L -30.24L -26.99L -24.9L -22.62L -42.44L -29Cr -3Cr -1.18Cr -15Cr -1.14Cr -1.11Cr -48Cr
Net Debt 70.92L 49.77L 44.42L 40.98L 37.23L 69.85L 47Cr 4.94Cr 1.94Cr 25Cr 1.87Cr 1.83Cr 78Cr -93.98L -65.94L -58.86L -54.3L -49.34L -92.56L -62Cr -6.54Cr -2.58Cr -33Cr -2.48Cr -2.42Cr -103.68Cr
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-